LABCORP HOLDINGS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LABCORP HOLDINGS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.95B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $13.01B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $12.16B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $11.86B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $13.14B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $13.98B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $2.95B | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $2.93B | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $2.88B | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $2.79B | Feb 28, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.70B | Feb 27, 2018 |
| FY2017 | Sep 30, 2017 | $2.60B | Feb 27, 2018 |
| FY2017 | Jun 30, 2017 | $2.50B | Feb 27, 2018 |
| FY2017 | Mar 31, 2017 | $2.41B | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $2.39B | Feb 27, 2018 |
| FY2017 | Sep 30, 2016 | $2.37B | Feb 27, 2018 |
| FY2017 | Jun 30, 2016 | $2.38B | Feb 27, 2018 |
| FY2017 | Mar 31, 2016 | $2.30B | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | $2.24B | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $2.27B | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.01B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.62B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.36B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $3.71B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $4.99B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $4.95B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $820.70M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $817.30M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $824.80M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $789.70M | Feb 28, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $876.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $746.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $418.00M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.28B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $2.38B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $1.56B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $227.10M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $220.70M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $190.40M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $185.60M | Feb 28, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $725.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.44B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $3.05B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $2.45B | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | $336.40M | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | $339.90M | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | $335.70M | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | $318.20M | Feb 28, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.23B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.02B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.76B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $1.69B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $1.73B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.62B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.57B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.50B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.35B | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $1.33B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $1.96B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $3.11B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $2.14B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.44B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.31B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.50B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.20B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $434.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $489.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $453.60M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $429.30M | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $421.50M | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $381.70M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $400.20M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $379.80M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $312.90M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $278.90M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.39B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $18.38B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $16.73B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $20.16B | Feb 26, 2024 |
| FY2021 | Dec 31, 2021 | $20.39B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $20.07B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $18.05B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $16.19B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $16.67B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $14.25B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.76B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $10.31B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $8.83B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $10.04B | Feb 26, 2024 |
| FY2021 | Dec 31, 2021 | $10.09B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $10.61B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $10.46B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $9.19B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $9.85B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $8.73B | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.62B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $8.05B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $7.88B | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $10.10B | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | $10.27B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $9.44B | Feb 26, 2024 |
| FY2021 | Dec 31, 2019 | $7.64B | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $7.05B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $6.80B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $5.52B | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.79B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $6.37B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $6.14B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $6.12B | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | $5.89B | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | $7.75B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $7.87B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $7.36B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $7.40B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $6.42B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.64B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $8.30B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $7.89B | Feb 25, 2025 |
| FY2024 | Dec 31, 2022 | $10.58B | Feb 25, 2025 |
| FY2024 | Dec 31, 2021 | $10.46B | Feb 25, 2025 |
| FY2023 | Dec 31, 2020 | $9.48B | Feb 26, 2024 |
| FY2021 | Dec 31, 2019 | $7.98B | Feb 28, 2023 |
| FY2021 | Dec 31, 2018 | $7.16B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $6.20B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $4.97B | Feb 28, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $532.30M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.52B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $536.80M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $320.60M | Feb 25, 2025 |
| FY2021 | Dec 31, 2021 | $1.47B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.32B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $337.50M | Feb 25, 2021 |
| FY2020 | Dec 31, 2018 | $426.80M | Feb 25, 2021 |
| FY2020 | Dec 31, 2017 | $316.60M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $433.60M | Feb 28, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $6.21B | Feb 28, 2020 |
| FY2018 | Dec 31, 2018 | $6.00B | Feb 28, 2019 |
| FY2017 | Dec 31, 2017 | $6.70B | Feb 27, 2018 |
| FY2016 | Dec 31, 2016 | $5.78B | Feb 27, 2017 |
| FY2015 | Dec 31, 2015 | $6.36B | Mar 1, 2016 |
| FY2014 | Dec 31, 2014 | $2.99B | Feb 26, 2015 |
| FY2013 | Dec 31, 2013 | $2.99B | Feb 25, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 14 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 24 | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | 15 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 28, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 8 | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | 13 | Feb 25, 2025 |
| FY2023 | Dec 31, 2021 | 24 | Feb 26, 2024 |
| FY2021 | Dec 31, 2020 | 15 | Feb 28, 2023 |
| FY2019 | Dec 31, 2019 | 2 | Feb 28, 2020 |
| FY2019 | Sep 30, 2019 | 2 | Feb 28, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 28, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 28, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 83.40M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 83.90M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | 88.20M | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | 93.10M | Feb 25, 2025 |
| FY2019 | Dec 31, 2019 | 97.20M | Feb 28, 2020 |
| FY2019 | Dec 31, 2018 | 98.90M | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | 101.90M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 102.70M | Feb 27, 2018 |
| FY2016 | Dec 31, 2015 | 101.30M | Feb 27, 2017 |